ABOUT SERVO BIOLABS

Advancing Protein Quality Control Science

Servo BioLabs is a biotechnology research company focused on ERAD—an essential cellular pathway that helps identify and clear misfolded proteins.

Our work explores how protein quality control, cellular stress, and loss of function contribute to metabolic disease, cognitive decline, neurodegeneration, and aging.

 

Our Technology

Servo BioLabs combines ERAD-modulator discovery with rapid fluorescence-based ERAD assays. These tools measure retrotranslocation, a key step in which selected misfolded proteins are moved out of the endoplasmic reticulum for degradation.

This platform helps us identify and characterize ERAD modulators, then study them in relevant cell systems and preclinical models.

​

Our Research

Our primary research areas include:

β-Cell Health
Cognition & Memory
Neurodegeneration & Aging

​

Our Vision

We aim to translate fundamental ERAD science into new approaches that help protect cellular function over time.

Selected natural-product research insights have also been translated into nutritional products. These products are not drugs and do not replace prescribed medical care.

From discovery to clinical translation, Servo BioLabs is building a global platform for longevity science—one rooted in scientific rigor, botanical innovation, and real-world health impact. Whether you're a scientist, partner, healthcare provider, or patient, we invite you to join us in this new era of precision aging solutions.

​

​